Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIDENT integrated anthelmintic co-administration study
PACTR202606574778281Phase 3Not yet recruiting
- Sponsor
- University of Dar Es Salaam Mbeya College of Health and Allied Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label trial of praziquantel in Soil-Transmitted Helminthiases (STH), schistosomiasis and Taenia solium infection (2 arms), sponsored by University of Dar Es Salaam Mbeya College of Health and Allied Sciences. Primary endpoints: Cumulative incidence of treatment-related adverse events, Safety profile of simultaneous single-day co-administration and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
praziquantel
03
Conditions
Soil-Transmitted Helminthiases (STH)schistosomiasisTaenia solium infection
Beyond the preview
Go deeper on PACTR202606574778281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606574778281.